Rivaroxaban 2.5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F7UG8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,395
Award facts
- Contract value 100% obligated
- $13,394.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rivaroxaban 2.5 mg tablets (60-count) with a ceiling value of $13,394.82. This competitive award, issued on December 5, 2025, represents a firm fixed price delivery order with an ultimate completion date of December 8, 2025. The contract is not set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated significant capability in fulfilling DLA medical supply chain requirements across multiple therapeutic domains. The company's extensive portfolio includes brand-name and generic medications, vaccines, and specialized healthcare commodities, with prior delivery orders ranging from minimal to substantial values exceeding $45,000. The Rivaroxaban delivery order supports the Defense Health Agency and broader military healthcare systems' anticoagulation therapy needs through AmerisourceBergen's established competitive procurement relationship with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26F7UG8?
SPE2DR26F7UG8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26F7UG8 worth?
The government has obligated $13,395 on SPE2DR26F7UG8.
Is contract SPE2DR26F7UG8 an order under another contract?
Yes. SPE2DR26F7UG8 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UG8 competed?
The extent of competition for SPE2DR26F7UG8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award